Login / Signup

Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.

Mohamed-Eslam F MohamedSandhya GirishRita HumeniukSilpa NuthalapatiAmit DesaiAmita Datta-MannanFerdous GheyasJitendra KanodiaSravanthi CheetiTong Zhu
Published in: Clinical pharmacology and therapeutics (2024)
Keyphrases
  • clinical trial
  • coronavirus disease
  • sars cov
  • phase ii
  • open label
  • randomized controlled trial
  • phase iii
  • double blind